Beijing Science Sun Pharmaceutical Co.,Ltd.’s Net Profit Rose 183.3% in First Half of 2022

Beijing Science Sun Pharmaceutical Co.,Ltd. (北京赛升药业股份有限公司) (300485.SZ) reported a net profit of 232.6 million yuan in the first half of 2022, up 183.3% year-on-year.

Meanwhile, the company posted 383.3 million yuan in revenue, down 26.6% year-on-year.

At the end of the reporting period, it had 3.5 billion yuan in total assets and 110.4 million yuan in total liabilities, with a liability-to-asset ratio of 3.1%.